Rovalpituzumab (Anti-DLL3)Rovalpituzumab (Anti-DLL3)
Move your mouse over image or click to enlarge

Rovalpituzumab (Anti-DLL3)

Rovalpituzumab (Anti-DLL3) is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC). MW: 145.5 KD.
Cat# Size Price Qty Buy
A2521-1mg*25 1mg*25
£1,941.00
A2521-1mg*5 1mg*5
£647.00
A2521-1mg 1mg
£221.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2521

Related Documents